Disc Medicine, Inc. is facing a class action lawsuit after the FDA issued a Complete Response Letter rejecting its new drug application for bitopertin due to uncertainties requiring more evidence. This announcement caused the company's stock to fall 22% on February 13, 2026. The Rosen Law Firm is investigating potential securities claims and preparing a class action to help investors recover losses without upfront fees. Investors who purchased Disc Medicine securities may be eligible to join the lawsuit for compensation.
XRP has surged more than 8% in three days following whale accumulation of approximately 1.54 billion tokens valued at $2.2 billion. This buying activity, combined with strong technical support and the upcoming XRP Ledger Batch V1.1 upgrade expected a...
Billionaire investor Tim Draper has called on major tech companies Apple and Meta to hold Bitcoin on their balance sheets as a safeguard against potential monetary instability caused by ongoing U.S. government spending and fiscal deficits. Draper arg...
Ethereum surged 4.8% to $2,752.53, nearing the $3,000 mark as BitMine increased its holdings by 27,562 ETH, now holding nearly 5% of total supply. Despite $140 million weekly outflows from US spot Ethereum ETFs, a sharp $143.8 million inflow on Frida...
The Harbor Ares Systematic High Yield ETF returned 3.11% in the second quarter, mainly due to effective security selection guided by Ares Systematic Credit’s proprietary Sentiment and Valuation research. The ETF favored higher-quality high yield bond...
Hi-View Resources CEO R. Nick Horsley will attend the 2026 Precious Metals Summit in Beaver Creek, Colorado, to meet investors and discuss the company’s gold, silver, and copper projects in British Columbia’s Toodoggone District. The summit is a key ...
